These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 12715330

  • 1. Are epidermal growth factor and transforming growth factor responsible for pseudoepitheliomatous hyperplasia associated with granular cell tumors?
    Barkan GA, Paulino AF.
    Ann Diagn Pathol; 2003 Apr; 7(2):73-7. PubMed ID: 12715330
    [Abstract] [Full Text] [Related]

  • 2. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
    Rubin Grandis J, Melhem MF, Barnes EL, Tweardy DJ.
    Cancer; 1996 Sep 15; 78(6):1284-92. PubMed ID: 8826952
    [Abstract] [Full Text] [Related]

  • 3. Expression of TGFalpha autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor.
    Jiang D, Liang J, Humphrey LE, Yang H, Brattain MG.
    J Cell Physiol; 1998 May 15; 175(2):174-83. PubMed ID: 9525476
    [Abstract] [Full Text] [Related]

  • 4. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
    Christensen ME.
    Dan Med Bull; 1998 Apr 15; 45(2):121-34. PubMed ID: 9587699
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
    Grandis JR, Tweardy DJ.
    Cancer Res; 1993 Aug 01; 53(15):3579-84. PubMed ID: 8339264
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.
    Srivastava A, Alexander J, Lomakin I, Dayal Y.
    Hum Pathol; 2001 Nov 01; 32(11):1184-9. PubMed ID: 11727256
    [Abstract] [Full Text] [Related]

  • 8. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.
    Shin DM, Ro JY, Hong WK, Hittelman WN.
    Cancer Res; 1994 Jun 15; 54(12):3153-9. PubMed ID: 8205534
    [Abstract] [Full Text] [Related]

  • 9. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
    Rubin Grandis J, Tweardy DJ, Melhem MF.
    Clin Cancer Res; 1998 Jan 15; 4(1):13-20. PubMed ID: 9516947
    [Abstract] [Full Text] [Related]

  • 10. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM, Saigal B, Donato NJ.
    J Cell Physiol; 2005 Nov 15; 205(2):218-27. PubMed ID: 15887238
    [Abstract] [Full Text] [Related]

  • 11. Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients.
    Scarisbrick JJ, Calonje E, Orchard G, Child FJ, Russell-Jones R.
    J Am Acad Dermatol; 2001 Feb 15; 44(2):239-47. PubMed ID: 11174381
    [Abstract] [Full Text] [Related]

  • 12. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO.
    Cancer; 2007 May 15; 109(10):2016-24. PubMed ID: 17394193
    [Abstract] [Full Text] [Related]

  • 13. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
    Modjtahedi H, Eccles S, Sandle J, Box G, Titley J, Dean C.
    Cancer Res; 1994 Apr 01; 54(7):1695-701. PubMed ID: 8137284
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S, Low I, Ng D, Brasch H, Sullivan M, Davis P, Tan ST.
    Hum Pathol; 2008 Mar 01; 39(3):344-9. PubMed ID: 18045646
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung.
    Tateishi M, Ishida T, Mitsudomi T, Kaneko S, Sugimachi K.
    Cancer Res; 1990 Nov 01; 50(21):7077-80. PubMed ID: 2208175
    [Abstract] [Full Text] [Related]

  • 16. Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas.
    Christensen ME, Therkildsen MH, Poulsen SS, Bretlau P.
    J Pathol; 1993 Mar 01; 169(3):323-8. PubMed ID: 8492225
    [Abstract] [Full Text] [Related]

  • 17. Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study.
    Wu X, Xin Y, Yao J, Hasui K, Tsuyama S, Yonezawa S, Murata F.
    Med Electron Microsc; 2001 Sep 01; 34(3):179-84. PubMed ID: 11793194
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
    Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
    Clin Cancer Res; 2002 Mar 01; 8(3):734-44. PubMed ID: 11895903
    [Abstract] [Full Text] [Related]

  • 19. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE, Lingen MW, Zhu B, Zhu H, Straza MW, Pierce C, Martin LE, Rosner MR.
    Cancer Res; 2006 Jun 15; 66(12):6296-303. PubMed ID: 16778206
    [Abstract] [Full Text] [Related]

  • 20. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C, Zlobec I, Stöckli E, Probst S, Storck C, Tornillo L, Lugli A, Wolfensberger M, Terracciano L.
    Hum Pathol; 2008 Oct 15; 39(10):1527-34. PubMed ID: 18620726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.